Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Vibrant Holdings LLC is a company patent portfolio with 2 pending office actions. These actions are located within the Biotechnology & Pharmaceuticals technology area. The prosecution of these matters is distributed between 2 distinct examiners. This distribution indicates that the portfolio is not under the review of only 1 individual. The data shows that 2 distinct art units are involved in the examination of these 2 pending office actions.
BROWN, MINDY G is the busiest examiner for this portfolio, with 1 pending office action. This 1 pending action for the busiest examiner is a portion of the 2 total pending office actions for the company. Because there are 2 distinct examiners for 2 actions, each examiner is handling a different matter. The involvement of 2 distinct art units suggests that the technical subject matter is being evaluated by different specialized groups within the patent office.
For the practitioner, this means that the 2 distinct examiners likely follow different art unit guidelines. The prosecution strategy must account for the specific prior art and technical standards recognized by 2 different art units. Having 2 distinct examiners and 2 distinct art units allows for a variety of perspectives on the Biotechnology & Pharmaceuticals filings, as they are spread across different technical departments.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| Double-patenting only | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BROWN, MINDY G | 1 | 57.8% | +40.5% |
| BUNKER, AMY M | 1 | 29.1% | +45.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18106443 | SUBSTRATES, SYSTEMS, AND METHODS FOR NUCLEIC ACID ARRAY SYNTHESIS | BUNKER, AMY M | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18368931 | METHODS, SYSTEMS, AND ARRAYS FOR BIOMOLECULAR ANALYSIS | BROWN, MINDY G | — |
| 18106443 | SUBSTRATES, SYSTEMS, AND METHODS FOR NUCLEIC ACID ARRAY SYNTHESIS | BUNKER, AMY M | — |
| Art Unit | Apps |
|---|---|
| 1634 | 1 |
| 1684 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18368931 | METHODS, SYSTEMS, AND ARRAYS FOR BIOMOLECULAR ANALYSIS | BROWN, MINDY G | 1634 | DP | Final Rejection | — | Pending | Sep 15, 2023 |
| 18106443 | SUBSTRATES, SYSTEMS, AND METHODS FOR NUCLEIC ACID ARRAY SYNTHESIS | BUNKER, AMY M | 1684 | §103 | Final Rejection | — | Pending | Feb 06, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialVibrant Holdings LLC has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Mindy G Brown has the most, with 1 of Vibrant Holdings LLC's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
